Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial Nephritis
Daisuke Nagata(Jichi Medical University), Kentaro Oka(Jichi Medical University), Kyohei Misawa(Jichi Medical University), Kazutoshi Ono(Jichi Medical University), Takahiro Masuda(Jichi Medical University), Tetsu Akimoto(Jichi Medical University), Maki Asakura-Kinoshita(Jichi Medical University), Kazuho Oe(Jichi Medical University), Yuko Ono(Dokkyo Medical University Saitama Medical Center), Natsuko Wakabayashi(Jichi Medical University), Chihiro Otsuki(Jichi Medical University), Erika Hishida(Jichi Medical University), Masato Sakai(Jichi Medical University)
Cited by 0
Related Papers
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling
|Circulation Research|2009|211
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume
|Physiological Reports|2020|135